# Osaka Gakuin University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/osaka-gakuin-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 63.7 |
| Citations | 171,511 |
| City | Suita |
| Country | JP |
| Description | Osaka Gakuin University is a research organisation in Suita, JP. OpenAlex records 4,025 works and 171,511 citations for it. 2,017 researchers list it as their most recent affiliation. |
| Homepage | https://www.osaka-gu.ac.jp/ |
| OpenAlex ID | https://openalex.org/I11381156 |
| Researchers | 2,017 |
| ROR ID | https://ror.org/04a8t1e98 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q860147 |
| Works | 4,025 |

## University papers

Showing 12 of 162.

- [Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure](https://scholariq.org/papers/universal-definition-and-classification-of-heart-failure-a-report-of-the-heart/)
- [Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source](https://scholariq.org/papers/comparison-of-human-stem-cells-derived-from-various-mesenchymal-tissues/)
- [Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial](https://scholariq.org/papers/nivolumab-versus-chemotherapy-in-patients-with-advanced-oesophageal-squamous/)
- [CEREBRAL BLOOD FLOW, BLOOD VOLUME AND OXYGEN UTILIZATION](https://scholariq.org/papers/cerebral-blood-flow-blood-volume-and-oxygen-utilization/)
- [The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial](https://scholariq.org/papers/the-sglt2-inhibitor-empagliflozin-in-patients-hospitalized-for-acute-heart/)
- [Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers](https://scholariq.org/papers/two-foxp3-cd4-t-cell-subpopulations-distinctly-control-the-prognosis-of/)
- [Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/everolimus-for-angiomyolipoma-associated-with-tuberous-sclerosis-complex-or/)
- [Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators](https://scholariq.org/papers/whole-genome-sequencing-of-liver-cancers-identifies-etiological-influences-on/)
- [Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs](https://scholariq.org/papers/reprogramming-of-mouse-and-human-cells-to-pluripotency-using-mature-micrornas/)
- [Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer](https://scholariq.org/papers/whole-genome-mutational-landscape-and-characterization-of-noncoding-and/)
- [Linking of Autophagy to Ubiquitin-Proteasome System Is Important for the Regulation of Endoplasmic Reticulum Stress and Cell Viability](https://scholariq.org/papers/linking-of-autophagy-to-ubiquitin-proteasome-system-is-important-for-the/)
- [JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure　― Digest Version ―](https://scholariq.org/papers/jcs-2017-jhfs-2017-guideline-on-diagnosis-and-treatment-of-acute-and-chronic/)

## University researchers

- [Yuichiro� Doki](https://scholariq.org/researchers/yuichiro-doki/)
- [Hidetoshi Eguchi](https://scholariq.org/researchers/hidetoshi-eguchi/)
- [Yoshitaka Isaka](https://scholariq.org/researchers/yoshitaka-isaka-2/)
- [Takayuki Hamano](https://scholariq.org/researchers/takayuki-hamano/)
- [Yusuke Sakaguchi](https://scholariq.org/researchers/yusuke-sakaguchi/)
- [Susumu Tanaka](https://scholariq.org/researchers/susumu-tanaka/)
- [Norikatsu Miyoshi](https://scholariq.org/researchers/norikatsu-miyoshi/)
- [Kōichi Deguchi](https://scholariq.org/researchers/koichi-deguchi/)
- [Shunsuke Yoshimoto](https://scholariq.org/researchers/shunsuke-yoshimoto/)
- [Misato Chimura](https://scholariq.org/researchers/misato-chimura/)
- [Yoshitaka Isaka](https://scholariq.org/researchers/yoshitaka-isaka/)

## University top topics

Showing 8 of 24.

- [Catalytic C–H Functionalization Methods](https://scholariq.org/topics/catalytic-c-h-functionalization-methods/)
- [Catalytic Cross-Coupling Reactions](https://scholariq.org/topics/catalytic-cross-coupling-reactions/)
- [VLSI and Analog Circuit Testing](https://scholariq.org/topics/vlsi-and-analog-circuit-testing/)
- [Oral microbiology and periodontitis research](https://scholariq.org/topics/oral-microbiology-and-periodontitis-research/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Integrated Circuits and Semiconductor Failure Analysis](https://scholariq.org/topics/integrated-circuits-and-semiconductor-failure-analysis/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Porphyrin and Phthalocyanine Chemistry](https://scholariq.org/topics/porphyrin-and-phthalocyanine-chemistry/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.